DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactOrders & Deals

Onyx Biotec Limited — Public Announcement-Open Offer

NSE 2 hrs ago·24 Jul 2026, 1:15 pm

Onyx Biotec

Onyx Biotec Limited has received a public announcement from VC Corporate Advisors Pvt Ltd regarding an open offer for the company's equity shares. This move signals that a potential acquirer is seeking to increase its stake in Onyx Biotec beyond the regulatory threshold of 25%.

For investors, this development indicates a possible change in control or significant influence over the company's future direction. The open offer price and the identity of the acquirer are key factors that will determine the offer's attractiveness to existing shareholders.

Investors should monitor the details of the offer, including the price and the number of shares being sought. The successful completion of this offer could lead to a change in the company's management or strategic focus, making it a significant event for the stock.